ITRM920349A0 - Composizioni farmaceutiche contenenti il-6 - Google Patents

Composizioni farmaceutiche contenenti il-6

Info

Publication number
ITRM920349A0
ITRM920349A0 IT92RM349A ITRM920349A ITRM920349A0 IT RM920349 A0 ITRM920349 A0 IT RM920349A0 IT 92RM349 A IT92RM349 A IT 92RM349A IT RM920349 A ITRM920349 A IT RM920349A IT RM920349 A0 ITRM920349 A0 IT RM920349A0
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
compositions containing
pharmaceutical
compositions
Prior art date
Application number
IT92RM349A
Other languages
English (en)
Inventor
Fabrizio Samaritani
Filippo Rendina
Original Assignee
Serono Cesare Ist Ricerca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Cesare Ist Ricerca filed Critical Serono Cesare Ist Ricerca
Publication of ITRM920349A0 publication Critical patent/ITRM920349A0/it
Priority to ITRM920349A priority Critical patent/IT1254359B/it
Priority to JP51984193A priority patent/JP3714951B2/ja
Priority to ES93909917T priority patent/ES2105257T3/es
Priority to PCT/EP1993/001120 priority patent/WO1993023065A1/en
Priority to DE69313444T priority patent/DE69313444T2/de
Priority to EP93909917A priority patent/EP0641216B1/en
Priority to CA002117761A priority patent/CA2117761C/en
Priority to AU40653/93A priority patent/AU676833B2/en
Priority to DK93909917.2T priority patent/DK0641216T3/da
Priority to US08/335,874 priority patent/US5635176A/en
Priority to AT93909917T priority patent/ATE157256T1/de
Publication of ITRM920349A1 publication Critical patent/ITRM920349A1/it
Application granted granted Critical
Publication of IT1254359B publication Critical patent/IT1254359B/it
Priority to GR970402352T priority patent/GR3024708T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/204IL-6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITRM920349A 1992-05-11 1992-05-11 Composizioni farmaceutiche contenenti il-6 IT1254359B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITRM920349A IT1254359B (it) 1992-05-11 1992-05-11 Composizioni farmaceutiche contenenti il-6
CA002117761A CA2117761C (en) 1992-05-11 1993-05-07 Pharmaceutical compositions containing il-6
DK93909917.2T DK0641216T3 (da) 1992-05-11 1993-05-07 Farmaceutisk præparat indeholdende IL-6
PCT/EP1993/001120 WO1993023065A1 (en) 1992-05-11 1993-05-07 Pharmaceutical compositions containing il-6
DE69313444T DE69313444T2 (de) 1992-05-11 1993-05-07 IL-6 ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN stabilisiert mit einem nicht-reduzierenden Zucker
EP93909917A EP0641216B1 (en) 1992-05-11 1993-05-07 PHARMACEUTICAL COMPOSITIONS CONTAINING IL-6 stabilized with a non-reducing sugar
JP51984193A JP3714951B2 (ja) 1992-05-11 1993-05-07 Il−6含有薬剤組成物
AU40653/93A AU676833B2 (en) 1992-05-11 1993-05-07 Pharmaceutical compositions containing IL-6
ES93909917T ES2105257T3 (es) 1992-05-11 1993-05-07 Composiciones farmaceuticas que contienen il-6 estabilizadas con un azucar no reductor.
US08/335,874 US5635176A (en) 1992-05-11 1993-05-07 Pharmaceutical compositions containing IL-6
AT93909917T ATE157256T1 (de) 1992-05-11 1993-05-07 Il-6 enthaltende pharmazeutische zusammensetzungen stabilisiert mit einem nicht- reduzierenden zucker
GR970402352T GR3024708T3 (en) 1992-05-11 1997-09-11 Pharmaceutical compositions containing il-6.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920349A IT1254359B (it) 1992-05-11 1992-05-11 Composizioni farmaceutiche contenenti il-6

Publications (3)

Publication Number Publication Date
ITRM920349A0 true ITRM920349A0 (it) 1992-05-11
ITRM920349A1 ITRM920349A1 (it) 1993-11-11
IT1254359B IT1254359B (it) 1995-09-14

Family

ID=11400994

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920349A IT1254359B (it) 1992-05-11 1992-05-11 Composizioni farmaceutiche contenenti il-6

Country Status (12)

Country Link
US (1) US5635176A (it)
EP (1) EP0641216B1 (it)
JP (1) JP3714951B2 (it)
AT (1) ATE157256T1 (it)
AU (1) AU676833B2 (it)
CA (1) CA2117761C (it)
DE (1) DE69313444T2 (it)
DK (1) DK0641216T3 (it)
ES (1) ES2105257T3 (it)
GR (1) GR3024708T3 (it)
IT (1) IT1254359B (it)
WO (1) WO1993023065A1 (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0679088B1 (en) 1992-09-29 2002-07-10 Inhale Therapeutic Systems Pulmonary delivery of active fragments of parathyroid hormone
ATE416755T1 (de) 1994-03-07 2008-12-15 Nektar Therapeutics Verfahren und zusammensetzung für die pulmonale darreichung von insulin
JP2000510813A (ja) * 1995-02-06 2000-08-22 ジェネテイックス・インスティテュート・インコーポレイテッド Il−12用処方
GB9508691D0 (en) * 1995-04-28 1995-06-14 Pafra Ltd Stable compositions
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
US5770700A (en) * 1996-01-25 1998-06-23 Genetics Institute, Inc. Liquid factor IX formulations
US6632648B1 (en) * 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US7141393B2 (en) * 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6433760B1 (en) 1999-01-14 2002-08-13 University Of Central Florida Head mounted display with eyetracking capability
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CA2433037C (en) 2000-12-28 2010-12-21 Takeda Chemical Industries, Ltd. Sustained-release preparation
PT1458360E (pt) 2001-12-19 2011-07-13 Novartis Ag Derivados de indole como agonistas do recetor s1p1
CN101721362B (zh) * 2002-02-14 2018-07-03 中外制药株式会社 包含抗体的溶液制剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4457916A (en) * 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
JPH0779694B2 (ja) * 1985-07-09 1995-08-30 カドラント バイオリソ−シズ リミテツド 蛋白質および同類品の保護
EP0835661B1 (en) * 1985-10-14 2007-08-29 Yeda Research And Development Co. Ltd. Human interferon-Beta2A for use as a medicament
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
DE3621828A1 (de) * 1986-06-28 1988-01-14 Biotest Pharma Gmbh Stabilisierung eines fuer therapeutische zwecke, insbesondere beim menschen, bestimmten interleukin-2-praeparates sowie dieses praeparat enthaltende stabilisierte waessrige loesung oder feststoff
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
US5104651A (en) * 1988-12-16 1992-04-14 Amgen Inc. Stabilized hydrophobic protein formulations of g-csf
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤
JPH0327320A (ja) * 1989-06-26 1991-02-05 Ajinomoto Co Inc ヒトb細胞分化因子医薬組成物
JPH05963A (ja) * 1990-04-13 1993-01-08 Toray Ind Inc ポリペプチド類組成物
US5416071A (en) * 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
CA2098008A1 (en) * 1991-10-09 1993-04-10 Tasuku Okamoto Agent for preventing or treating hemorrhage tendency
JP3027320U (ja) 1996-01-27 1996-08-09 三千男 高橋 野球グラブの装着補強具

Also Published As

Publication number Publication date
IT1254359B (it) 1995-09-14
AU4065393A (en) 1993-12-13
DE69313444D1 (de) 1997-10-02
EP0641216B1 (en) 1997-08-27
ATE157256T1 (de) 1997-09-15
US5635176A (en) 1997-06-03
AU676833B2 (en) 1997-03-27
GR3024708T3 (en) 1997-12-31
DK0641216T3 (da) 1998-01-26
ITRM920349A1 (it) 1993-11-11
EP0641216A1 (en) 1995-03-08
ES2105257T3 (es) 1997-10-16
WO1993023065A1 (en) 1993-11-25
JP3714951B2 (ja) 2005-11-09
CA2117761A1 (en) 1993-11-25
CA2117761C (en) 2005-10-04
DE69313444T2 (de) 1998-01-02
JPH08502722A (ja) 1996-03-26

Similar Documents

Publication Publication Date Title
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777L (fi) Farmaseuttinen ainekoostumus
FI922316L (fi) Farmaceutisk sammansaettning
FI922364A7 (fi) Farmaseuttiset koostumukset
FI901102A7 (fi) Farmaseuttiset koostumukset
FI950166A7 (fi) Uudet farmaseuttiset koostumukset
FI944123L (fi) Farmaseuttiset inhalaatiokoostumukset
NO179941C (no) Farmasöytisk forbindelse
FI925661L (fi) Injicerbar farmaceutisk komposition
ITRM910952A0 (it) Composizioni farmaceutiche contenenti gonadotropine
ITRM920349A0 (it) Composizioni farmaceutiche contenenti il-6
FI893643A7 (fi) Farmaseuttisia koostumuksia
FI943261L (fi) Farmaseuttiset bakteriosiinikoostumukset
MX9200622A (es) Composicion farmaceutica
NO934145L (no) Farmasöytiske forbindelser
FI931251A7 (fi) Farmaseuttisia yhdisteitä
FI943705L (fi) Farmaseuttiset koostumukset
IT1290797B1 (it) Composizioni farmaceutiche stabilizzate
FI940726L (fi) Farmaseuttiset koostumukset
FI952377A7 (fi) Farmaseuttisia ibuprofeenikoostumuksia
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
DK0599461T3 (da) Hærdelige sammensætninger
FI910773A7 (fi) Episialo-hiilihydraattikompleksia sisältävä farmaseuttinen koostumus
ITMI922580A1 (it) Composizione farmaceutica